神经重症监护中脑灌注压换能器放置难题的解决方案?双换能器
脑灌注压(CPP)是脑血流的驱动压并用于指导治疗,但文献中动脉压换能器放置位置不一致,导致平均动脉压(MAP)因患者体位和换能器位置不同可相差达15 mm Hg。生理上换能器应置于室间孔水平,但常规置于右心房水平;右心房水平测量在抬高头部时可能高估MAP并导致实际CPP过低,室间孔水平测量则低估全身血压,增加过度使用血管升压药和液体的风险。瑞典卡罗林斯卡大学医院神经重症监护病房使用分体式双换能器系统,从单一动脉源同时测量室间孔和右心房水平的动脉压,以常数工作并监测目标动脉压,可能降低脑缺血或过度使用血管升压药和液体的风险,从而可能影响预后。
要点
- 动脉压换能器放置位置不同可使CPP计算所用的MAP相差最多达15 mm Hg,超过临床目标范围可接受的变异。
- 右心房水平测量MAP在头部抬高时可能高估CPP,导致实际CPP低至危险水平。
- 室间孔水平测量MAP会低估全身血压,增加过度和不必要使用血管升压药及液体的风险。
- 卡罗林斯卡大学医院神经重症监护病房使用分体式双换能器系统,从单一动脉源同时测量室间孔和右心房水平动脉压。
- 作者认为双换能器系统可监测并目标化最佳动脉压以更好保障所有器官灌注,可能降低脑缺血或过度使用血管升压药和液体的风险。
适用人群与场景
- 大多数收治严重神经损伤患者的重症监护病房中常规监测颅内压的患者。
- 需要同时连续监测动脉血压以计算脑灌注压(CPP)并指导治疗的患者。
处置流程与药物剂量
- 生理上动脉压换能器应置于室间孔水平用于CPP测量。
- 常规系统测量常将换能器置于右心房水平。
- 卡罗林斯卡大学医院神经重症监护病房使用分体式双换能器系统,从单一动脉源同时测量室间孔水平和右心房水平的动脉压。
证据类型、等级与局限
- 证据类型:专家意见/单中心经验描述(来自卡罗林斯卡大学医院神经重症监护病房的实践描述)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用分体式双换能器系统同时测量室间孔和右心房水平动脉压,可以常数工作并监测和目标化最佳动脉压,以更好保障所有器官灌注,可能降低脑缺血或过度使用血管升压药和液体的风险,从而可能影响预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Intracranial pressure is routinely monitored in most intensive care units caring for patients with severe neurological insults and, together with continuous arterial blood pressure measurement, allows for monitoring of cerebral perfusion pressure (CPP). CPP is the driving pressure of blood flow to the brain and is used to guide therapy. However, there is considerable inconsistency in the literature regarding how CPP is technically measured and, more specifically, the appropriate placement of the arterial pressure transducer. Depending on patient positioning and where the arterial pressure transducer is placed, the mean arterial pressure used for CPP calculation can vary widely by up to 15 mm Hg, which is greater than the acceptable variation in target ranges used clinically. Physiologically, the arterial pressure transducer should be placed at the level of the foramen of Monro for CPP measurement, but it is commonly set at the level of the right atrium for systematic measurement. Mean arterial pressure measurement at the level of the right atrium can lead to overestimation and potentially critically low actual CPP levels when the head is elevated, and measurement at the level of the foramen of Monro will underestimate systemic pressures, increasing the risk of excessive and unnecessary use of vasopressors and fluid. At the Karolinska University Hospital neurointensive care unit, we have used a split dual-transducer system, measuring arterial pressure both at the level of the foramen of Monro and at the level of the right atrium from a single arterial source. In doing so, we work with constants and can monitor and target optimum arterial pressures to better secure perfusion to all organs, with potentially less risk of cerebral ischemia or overuse of vasopressors and fluids, which may affect outcome.
参考来源
- Mikkonen E, Blixt J, Ercole A, et al. A Solution to the Cerebral Perfusion Pressure Transducer Placement Conundrum in Neurointensive Care? The Dual Transducer. Neurocrit Care. 2023. PMID: 37697130. doi:10.1007/s12028-023-01829-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。